234080.KS
JW Lifescience Corporation
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 11,200.00
−1.67%Leverage
- Debt / equity
- 0.14x
- Net debt / equity
- 0.10x
- Debt / assets
- 0.11x
- Debt / EBITDA
- 0.62x
- Net debt / EBITDA
- 0.45x
Liquidity & coverage
- Current ratio
- 1.25x
- Quick ratio
- 0.81x
- Cash ratio
- 0.14x
- Interest coverage
- 23.41x
- EBITDA / interest
- 36.37x
- Working capital
- KRW 16.5B
Cash & dividend
- FCF / debt
- 1.10x
- Cash flow / debt
- 1.48x
- Dividend per share
- KRW 550
- Dividend yield
- 4.9%
- Dividend growth 1y
- +10.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026